Enhancement of basophil apoptosis by olopatadine and theophylline

Allergy and Asthma Proceedings

Volumn 29, Issue 3, 2008, Pages 322-328

  Kawakami, Ayako ^a   Suzukawa, Maho ^a   Koketsu, Rikiya ^a   Komiya, Akiko ^a   Ohta, Ken ^b   Yamamoto, Kazuhiko ^a   Yamaguchi, Masao ^a  

^a UNIVERSITY OF TOKYO   (Japan)

^b TEIKYO UNIVERSITY   (Japan)

Author keywords

Allergy; Annexin V; Apoptosis; Basophils; Flow cytometry; Human; Interleukin 3; Mitochondria; Olopatadine; Theophylline

Indexed keywords

DIBENZOXEPIN DERIVATIVE; OLOPATADINE; THEOPHYLLINE;

APOPTOSIS; ARTICLE; BASOPHIL; BLOOD; CELL MEMBRANE POTENTIAL; CELL SEPARATION; CELL SURVIVAL; CULTURE TECHNIQUE; DOSE RESPONSE; DRUG EFFECT; FLOW CYTOMETRY; HUMAN; IMMEDIATE TYPE HYPERSENSITIVITY; IMMUNOLOGY; PATHOLOGY;

APOPTOSIS; BASOPHILS; CELL CULTURE TECHNIQUES; CELL SEPARATION; CELL SURVIVAL; DIBENZOXEPINS; DOSE-RESPONSE RELATIONSHIP, DRUG; FLOW CYTOMETRY; HUMANS; HYPERSENSITIVITY, IMMEDIATE; MEMBRANE POTENTIALS; THEOPHYLLINE;

EID: 46649087129     PISSN: 10885412     EISSN: None     Source Type: Journal    
DOI: 10.2500/aap.2008.29.3118     Document Type: Article

References (27)

1. Ishizaka T, and Ishizaka K. Activation of mast cells for mediator release through IgE receptors. Prog Allergy 34:188-235, 1984.
2. Guo CB, Liu MC, Galli SJ, et al. Identification of IgE-bearing cells in the late-phase response to antigen in the lung as basophils. Am J Respir Cell Mol Biol 10:384-390, 1994.
3. Iliopoulos O, Baroody FM, Naclerio RM, et al. Histamine-containing cells obtained from the nose hours after antigen challenge have functional and phenotypic characteristics of basophils. J Immunol 148:2223-2228, 1992.
4. Charlesworth EN, Hood AF, Soter NA, et al. Cutaneous late-phase response to allergen. Mediator release and inflammatory cell infiltration. J Clin Invest 83:1519-1526, 1989.
5. Koshino T, Teshima S, Fukushima N, et al. Identification of basophils by immunohistochemistry in the airways of postmortem cases of fatal asthma. Clin Exp Allergy 23:919-925, 1993.
6. Kepley CL, McFeeley PJ, Oliver JM, et al. Immunohistochemical detection of human basophils in postmortem cases of fatal asthma. Am J Respir Crit Care Med 164:1053-1058, 2001.
7. Naclerio RM, Proud D, Togias AG, et al. Inflammatory mediators in late antigen-induced rhinitis. N Engl J Med 313:65-70, 1985.
8. Barnes PJ. Anti-inflammatory actions of glucocorticoids: Molecular mechanisms. Clin Sci 94:557-572, 1998.
9. Barnes PJ. Inhaled glucocorticoids for asthma. N Engl J Med 332:868-875, 1995.
10. Schleimer RP, Derse CP, Friedman B, et al. Regulation of human basophil mediator release by cytokines. I. Interaction with antiinflammatory steroids. J Immunol 143:1310-1317, 1989.
11. Yoshimura C, Miyamasu M, Nagase H, et al. Glucocorticoids induce basophil apoptosis. J Allergy Clin Immunol 108:215-220, 2001.
12. Iikura M, Yamaguchi M, Fujisawa T, et al. Secretory IgA induces degranulation of IL-3-primed basophils. J Immunol 161: 1510-1515, 1998.
13. Smiley ST, Reers M, Mottola-Hartshorn C, et al. Intracellular heterogeneity in mitochondrial membrane potentials revealed by a J-aggregate-forming lipophilic cation JC-1. Proc Natl Acad Sci U S A 88:3671-3675, 1991.
14. Reers M, Smith TW, and Chen LB. J-aggregate formation of a carbocyanine as a quantitative fluorescent indicator of membrane potential. Biochemistry 30:4480-4486, 1991.
15. Yoshimura-Uchiyama C, Yamaguchi M, Nagase H, et al. Comparative effects of basophil-directed growth factors. Biochem Biophys Res Commun 302:201-206, 2003.
16. Ohta K, Sawamoto S, Nakajima M, et al. The prolonged survival of human eosinophils with interleukin-5 and its inhibition by theophylline via apoptosis. Clin Exp Allergy 26:S10-S15, 1996.
17. Abelson MB, Gomes PJ, Pasquine T, et al. Efficacy of olopatadine ophthalmic solution 0.2% in reducing signs and symptoms of allergic conjunctivitis. Allergy Asthma Proc 28:427-433, 2007.
18. Miyake K, Ohmori K, Ishii A, et al. Inhibitory effect of olopatadine hydrochloride (KW-4679), a novel antiallergic drug, on peptide leukotriene release from human eosinophils. Allergol Int 50:113-116, 2001.
19. Ikemura T, Manabe H, Sasaki Y, et al. KW-4679, an antiallergic drug, inhibits the production of inflammatory lipids in human polymorphonuclear leukocytes and guinea pig eosinophils. Int Arch Allergy Immunol 110:57-63, 1996.
20. Chung KF. Theophylline in chronic asthma-evidence for disease-modifying properties. Clin Exp Allergy 26:S22-S27, 1996.
21. Weston MC, Anderson N, and Peachell PT. Effects of phosphodiesterase inhibitors on human lung mast cell and basophil function. Br J Pharmacol 121:287-295, 1997.
22. Wang CH, Lin HC, Lin CH, et al. Effect of theophylline and specific phosphodiesterase IV inhibition on proliferation and apoptosis of progenitor cells in bronchial asthma. Br J Pharmacol 138:1147-1155, 2003.
23. Shichijo M, Inagaki N, Nakai N, et al. The effects of anti-asthma drugs on mediator release from cultured human mast cells. Clin Exp Allergy 28:1228-1236, 1998.
24. Eskandari N, Wickramasinghe T, and Peachell PT. Effects of phosphodiesterase inhibitors on interleukin-4 and interleukin-13 generation from human basophils. Br J Pharmacol 142: 1265-1272, 2004.
25. Yasui K, Hu B, Nakazawa T, et al. Theophylline accelerates human granulocyte apoptosis not via phosphodiesterase inhibition. J Clin Invest 100:1677-1684, 1997.
26. Marone G, Spadaro G, De Marino V, et al. Immunopharmacology of human mast cells and basophils. Int J Clin Lab Res 28:12-22, 1998.
27. Strunk RC, and Bloomberg GR. Omalizumab for asthma. N Engl J Med 354:2689-2695, 2006.